Gestational diabetes (GDM) refers to abnormal glucose metabolism of different degrees that occurs or is first found during pregnancy, which is characterized by a potential defect in the response of pancreatic beta cells to insulin during pregnancy, which can have adverse effects on perinatal and maternal postpartum outcomes [1, 2]. This evidence concerns the gene INS and gestational diabetes.